Literature DB >> 6272177

An autopsy study of hepatocellular carcinoma in Hong Kong.

J Ho, P C Wu, T M Kung.   

Abstract

Two hundred and eighty-seven autopsy cases of hepatocellular carcinoma (HCC) in Chinese were reviewed. The analyses included histological study of the tumour and of the non-cancerous liver tissue, the cause of death and metastases. Bleeding of oesophageal varices was more frequent but rupture of tumour less common in cases associated with cirrhosis than in those without cirrhosis. There was a significantly higher incidence of bilobar involvement by tumour in the clear cell type of HCC and in cases unassociated with cirrhosis compared to other histological types of HCC and HCC with cirrhosis, possibly because of longer survival of the former groups. A strong association was found between cirrhosis and hepatic fibrosis with HCC and hepatitis B surface antigen (HBsAg), suggesting an oncogenic effect of chronic persistent hepatitis B virus (HBV) infection on hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272177     DOI: 10.3109/00313028109059059

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  13 in total

1.  Metastasis in an axillary lymph node in hepatocellular carcinoma:a case report.

Authors:  Michael R Alison; Gladwyn Leiman; Michael C Kew
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Transjugular intrahepatic portasystemic stent shunt in the treatment of variceal bleeding in hepatocellular cancer.

Authors:  F M Serafini; B Zwiebel; T J Black; L C Carey; A S Rosemurgy
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

3.  Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.

Authors:  P C Wu; J W Fang; V K Lau; C L Lai; C K Lo; J Y Lau
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

4.  Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma.

Authors:  Jerzy Kaczynski; Göran Hansson; Sven Wallerstedt
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

5.  Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma.

Authors:  Jianhua Li; Xinguang Qiu; Wenzhi Guo; Bing Yan; Shuijun Zhang
Journal:  Med Oncol       Date:  2015-09-02       Impact factor: 3.064

6.  A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma.

Authors:  W Yeo; J Y Sung; S C Ward; S C Chung; W Y Lee; A K Li; P J Johnson
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

7.  Sclerotherapy for esophageal variceal bleeding in advanced hepatocellular carcinoma: an 8-year experience in Taiwan.

Authors:  C Y Cheng; G H Chen; C S Chang; C C Tseng; H K Pan; C K Huang; P F Hsieh
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

Review 8.  Metastatic hepatocellular carcinoma of the external auditory canal.

Authors:  Ryuji Yasumatsu; Kenji Okura; Yumiko Sakiyama; Makoto Nakamuta; Taisei Matsumura; Satoru Uehara; Tomoya Yamamoto; Shizuo Komune
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

9.  Solitary Asymptomatic Thyroid Metastasis from Hepatocellular Carcinoma Detected by FDG-PET/CT.

Authors:  Takeo Toshima; Akinobu Taketomi; Ken Shirabe; Kazuki Takeishi; Takashi Motomura; Youhei Mano; Kazutoyo Morita; Takasuke Fukuhara; Keishi Sugimachi; Yasuhiro Maruoka; Koichiro Abe; Tsuyoshi Tajima; Yoshihiko Maehara
Journal:  Case Rep Gastroenterol       Date:  2010-08-02

10.  Ileovesical fistula caused by hepatocellular carcinoma.

Authors:  Jeong Rae Byun; Sang Hee Cho; Deok Hwan Yang; Yeo Kyeoung Kim; Jae Kyun Ju; Sung Kyu Choi; Ik Joo Chung
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.